ARCHIVED - 2009 - Preliminary Results

Warning This page has been archived.

Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.

Figure 38. Resistance to antimicrobials in Salmonella isolates from turkeys; Surveillance of Animal Clinical Isolates, 2009

Categorization of antimicrobials based on importance in human medicine	Antimicrobial	zspecies	bspecies	project	Turkeys (n = 60)
	Antimicrobial	zspecies	bspecies	project	N_ON	ATM	P	LCL	UCL	EBMINUS	EBPLUS
IV
III	Tetracycline	Turkey	Salmonella	Diagnostic / clinical cases	60	TET	0.31666667	0.203	0.45	0.114091	0.13289
	Sulfisoxazole					SSS	0.28333333	0.175	0.414	0.108828	0.1311
	Chloramphenicol					CHL	0.01666667	4E-04	0.089	0.016245	0.07273
II	Trimethoprim-sulfamethoxazole					SXT	0.01666667	4E-04	0.089	0.016245	0.07273
	Streptomycin					STR	0.3	0.188	0.432	0.111549	0.13208
	Nalidixic acid					NAL	0	0	0.049	0	0.0487
	Kanamycin					KAN	0.08333333	0.028	0.184	0.05572	0.10052
	Gentamicin					GEN	0.08333333	0.028	0.184	0.05572	0.10052
	Cefoxitin					FOX	0.26666667	0.161	0.397	0.10592	0.12994
	Ampicillin					AMP	0.26666667	0.161	0.397	0.10592	0.12994
	Amikacin					AMK	0	0	0.049	0	0.0487
I	Ciprofloxacin					CIP	0	0	0.049	0	0.0487
	Ceftriaxone					CRO	0.26666667	0.161	0.397	0.10592	0.12994
	Ceftiofur					TIO	0.26666667	0.161	0.397	0.10592	0.12994
	Amoxicillin-clavulanic acid					AMC	0.26666667	0.161	0.397	0.10592	0.12994

Return to the figure